Johnson & Johnson Market Cap 2006-2019 | JNJ

Johnson & Johnson market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Johnson & Johnson market cap as of May 17, 2019 is $371.88B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $371.877B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $246.865B 13.46
Merck (MRK) United States $212.244B 17.45
Novartis AG (NVS) Switzerland $191.037B 16.51
AbbVie (ABBV) United States $117.468B 9.71
Novo Nordisk (NVO) Denmark $114.333B 19.02
Eli Lilly (LLY) United States $112.626B 20.90
Sanofi (SNY) France $105.089B 12.89
GlaxoSmithKline (GSK) United Kingdom $97.884B 12.41
AstraZeneca (AZN) United Kingdom $95.693B 11.01
Bristol-Myers Squibb (BMY) United States $76.633B 11.32